Search Results - "Molitch, M. E"

Macimorelin (AEZS-130)-Stimulated Growth Hormone (GH) Test: Validation of a Novel Oral Stimulation Test for the Diagnosis of Adult GH Deficiency by Garcia, J. M, Swerdloff, R, Wang, C, Kyle, M, Kipnes, M, Biller, B. M. K, Cook, D, Yuen, K. C. J, Bonert, V, Dobs, A, Molitch, M. E, Merriam, G. R

“…Context: In the absence of panhypopituitarism and low serum IGF-I levels, the diagnosis of adult GH deficiency (AGHD) requires confirmation with a GH…”
Get full text

Disorders of prolactin secretion by Molitch, M E

“…Prolactinomas are a common cause of reproductive/sexual dysfunction. Once other causes of hyperprolactinemia have been excluded with a careful history and…”
Get more information

Medical treatment of prolactinomas by Molitch, M E

“…Prolactinomas are a common cause of reproductive and sexual dysfunction. Once other causes of hyperprolactinemia have been excluded with a careful history,…”
Get more information

Octreotide as primary therapy for acromegaly by NEWMAN, C. B, MELMED, S, SHEELER, L, COOK, D, MALARKEY, W, JACKSON, I, VANCE, M. L, BARKAN, A, FROHMAN, L, KLEINBERG, D. L, GEORGE, A, TORIGIAN, D, DUHANEY, M, SNYDER, P, YOUNG, W, KLIBANSKI, A, MOLITCH, M. E, GAGEL, R

“…The effects of octreotide (up to 5 yr) as primary treatment in 26 patients with acromegaly were compared with those in 81 patients with acromegaly who received…”
Get full text

Clinical manifestations of acromegaly by Molitch, M E

“…Acromegaly is an uncommon disorder and may present in a variety of ways, leading to considerable delay in diagnosis. Unlike other pituitary tumors, tumors…”
Get more information

Growth hormone treatment in adults with growth hormone deficiency: The transition by Molitch, M. E.

“…The approval of GH treatment of adults with GH deficiency (GHD) raises issues regarding continuation of GH treatment in the GH-deficient child following…”
Get full text

Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency by PURDY, L. P, HANTSCH, C. E, MOLITCH, M. E, METZGER, B. E, PHELPS, R. L, DOOLEY, S. L, HOU, S. H

“…Effect of pregnancy on renal function in patients with moderate-to-severe diabetic renal insufficiency. L P Purdy , C E Hantsch , M E Molitch , B E Metzger , R…”
Get full text

Cerebrovascular disorders in patients with diabetes mellitus by Mankovsky, Boris N, Metzger, Boyd E, Molitch, Mark E, Biller, Jose

“…Diabetes mellitus is a risk factor for ischemic, but not hemorrhagic stroke. The frequency of transient ischemic attacks is not increased in patients with…”
Get full text

Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline by BILLER, B. M. K, MOLITCH, M. E, VANCE, M. L, CANNISTRARO, K. B, DAVIS, K. R, SIMONS, J. A, SCHOENFELDER, J. R, KLIBANSKI, A

“…Dopamine agonist administration is the primary therapy for macroprolactinomas, but bromocriptine is the only agent approved in the United States. Its use is…”
Get full text

Pituitary incidentalomas by Molitch, M E

“…Incidental pituitary masses are commonly found during CT and MR imaging performed for a variety of reasons. Screening for hormone oversecretion by these tumors…”
Get more information

Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study by Newman, C B, Melmed, S, Snyder, P J, Young, W F, Boyajy, L D, Levy, R, Stewart, W N, Klibanski, A, Molitch, M E, Gagel, R F

“…One hundred and three acromegalic patients from 14 medical centers were enrolled in this study to determine the efficacy and safety of the somatostatin analog,…”
Get more information

Pituitary diseases in pregnancy by Molitch, Mark E.

“…Pituitary adenomas are the most common pituitary disorder affecting pregnancy, and prolactinomas are the most common of the hormone-secreting pituitary…”
Get full text

Octreotide treatment of acromegaly. A randomized, multicenter study by Ezzat, S, Snyder, P J, Young, W F, Boyajy, L D, Newman, C, Klibanski, A, Molitch, M E, Boyd, A E, Sheeler, L, Cook, D M

“…To determine the effects of the somatostatin analog, octreotide acetate, in patients with acromegaly. Double-blind, randomized trial. Fourteen…”
Get more information

Mechanism of verapamil calcium channel blockade-induced hyperprolactinemia by Kelley, S R, Kamal, T J, Molitch, M E

“…Verapamil, a phenylalkylamine calcium channel blocker, causes a doubling of serum prolactin (PRL) levels in humans. To determine whether the mechanism involved…”
Get full text

Diagnosis and treatment of prolactinomas by Molitch, M E

Get more information

Relationship Between Hyperglycemia and Heart Transplant Rejection by Mateo, R, Gupta, S, Wallia, A, Cameron, C, Schmidt, K, Oakes, D.J, Aleppo, G, Andrei, A.-C, Wilcox, J.E, Grady, K, Gordon, R, Molitch, M.E

“…Abstract Purpose Hyperglycemia increases risks of kidney and liver transplant rejection. To determine whether perioperative and subsequent glycemic control was…”
Get full text

Management of early diabetic nephropathy by Molitch, M E

Get more information

Therapeutic controversy : Management of prolactinomas by MOLITCH, M. E, THORNER, M. O, WILSON, C

Get full text

Endocrine problems in the chronically critically ill patient by Vasa, F R, Molitch, M E

“…The endocrine adaptations to critical illness are varied. In the diabetic patient, counterregulatory hormones predispose to insulin resistance and…”
Get more information

Low plasma growth hormone binding protein in IDDM by Mercado, M., Molitch, M. E., Baumann, G.

“…Low plasma growth hormone binding protein in IDDM. M Mercado , M E Molitch and G Baumann Department of Medicine, Northwestern University Medical School,…”
Get full text